Vaccines News and Research RSS Feed - Vaccines News and Research

Viewpoints: Many beneficiaries of health law don't vote; reboot for healthcare.gov

Viewpoints: Many beneficiaries of health law don't vote; reboot for healthcare.gov

For starters, my strong hunch from my own reporting in the region over the past couple years-;including several trips to Kentucky for a new book on McConnell-;is that the Democrats' biggest problem in Appalachia and the Upland South is not that the people who are benefitting from Obamacare or would stand to benefit from it if their states fully implemented the law are voting against their own interests, for Republicans. [More]
Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

Soligenix awarded $24.7 million contract to advance development of Rivax vaccine

Soligenix, Inc., a late-stage biopharmaceutical company developing products that address unmet medical needs in the areas of inflammation, oncology and biodefense, announced today that it has been awarded a contract valued at up to $24.7 million inclusive of options by the US Department of Health and Human Service's National Institutes of Health (specifically funded by the National Institute of Allergy and Infectious Diseases or NIAID). [More]
Getting a flu vaccination helps moms help their babies

Getting a flu vaccination helps moms help their babies

Only about half of all pregnant women in the U.S. get a flu shot each season, leaving thousands of moms-to-be and their babies at increased risk of serious illness. [More]
Janssen announces availability of PREZCOBIX for Canadians living with HIV

Janssen announces availability of PREZCOBIX for Canadians living with HIV

Janssen Inc. announced today that PREZCOBIX (darunavir/cobicistat), a once-daily, oral medication for the treatment of HIV infection in combination with other antiretroviral agents, is now available in Canada. It is the first HIV treatment option available to patients that provides boosted darunavir in a single tablet. [More]
GHIT Fund announces new grants to tackle malaria, chagas disease and dengue

GHIT Fund announces new grants to tackle malaria, chagas disease and dengue

The Global Health Innovative Technology Fund, a new public health partnership that is bringing Japanese know-how and investment to the global fight against infectious diseases, today announced seven grant investments totaling US$15.3 million to speed the development of promising drugs and vaccines to battle three insect-borne diseases-malaria, dengue and Chagas disease. [More]
Massive global response needed to prevent Ebola infection, say experts

Massive global response needed to prevent Ebola infection, say experts

The current Ebola outbreak now requires a "rapid response at a massive global scale", according to experts at the London School of Hygiene & Tropical Medicine. [More]
Getting flu shot every autumn can lead to better health

Getting flu shot every autumn can lead to better health

Everyone knows that the best way to avoid the flu is by getting an annual flu shot. But a trip to your physician every autumn for the vaccination can help you avoid much more than the dreaded flu bug. "At the doctor's office, the focus is on you and what is going on with your health. This is your time to talk about concerns to improve your well-being beyond the flu season," says Jorge Parada, MD, MPH, the medical director of the Infection Prevention and Control Program at Loyola University Health System. [More]
Gastroenterologist hopes to achieve healthy growth and development in children around the world

Gastroenterologist hopes to achieve healthy growth and development in children around the world

Why is it harder for kids in low- and middle-income countries to grow as well as kids in wealthy countries? Food security, or access to good nutrition, remains a major challenge. The issue is not just food supply but poor sanitation - a problem exacerbated by local infrastructure and cultural mores. [More]
Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

Cancer Research UK, CRT partner with Asterias to trail novel immunotherapy treatment for lung cancer

CANCER RESEARCH UK and Cancer Research Technology , the charity's development and commercialisation arm, have reached an agreement with Asterias Biotherapeutics, Inc., a biotechnology company in the emerging field of regenerative medicine, to take forward Asterias' novel immunotherapy treatment AST-VAC2 into clinical trials in subjects with non-small cell lung cancer. [More]
AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie’s Phase 3 pivotal study shows HUMIRA is effective in reducing symptoms in HS

AbbVie today announced results from a Phase 3 pivotal study demonstrating that HUMIRA® (adalimumab) is effective in reducing common clinical signs and symptoms in moderate-to-severe hidradenitis suppurativa (HS), specifically the number of abscesses and inflammatory nodules. [More]
Gates Foundation pledges $50 million to support emergency efforts to control Ebola epidemic

Gates Foundation pledges $50 million to support emergency efforts to control Ebola epidemic

The Bill & Melinda Gates Foundation today announced that it will commit $50 million to support the scale up of emergency efforts to contain the Ebola outbreak in West Africa and interrupt transmission of the virus. [More]
Sanofi contributes $2.5 million to CCNA for dementia research

Sanofi contributes $2.5 million to CCNA for dementia research

Sanofi announced today its $2.5 million contribution to co-fund the Canadian Consortium on Neurodegeneration in Aging, a partnership officially launched in Montreal today in the presence of The Honourable Rona Ambrose, Minister of Health. [More]
USFDA clears Caya- contoured diaphragm for marketing in the United States

USFDA clears Caya- contoured diaphragm for marketing in the United States

The United States Food and Drug Administration (USFDA) has cleared the Caya- contoured diaphragm for marketing in the United States, bringing women one step closer to a new option for safe and effective non-hormonal contraception. [More]
Moms should be vaccinated for whooping cough during third trimester

Moms should be vaccinated for whooping cough during third trimester

Expectant moms should be vaccinated for pertussis, or whooping cough, during their third trimester, according to obstetricians at Loyola University Health System. Those in close contact with the infant also should be up to date with their whooping cough vaccine. [More]
Alzheimer's disease report success in harnessing mouse's immune system to attack toxic proteins

Alzheimer's disease report success in harnessing mouse's immune system to attack toxic proteins

Alzheimer's disease experts at NYU Langone Medical Center and elsewhere are reporting success in specifically harnessing a mouse's immune system to attack and remove the buildup of toxic proteins in the brain that are markers of the deadly neurodegenerative disease. [More]
SLU researchers work to prevent several serious infectious diseases

SLU researchers work to prevent several serious infectious diseases

Saint Louis University researchers are attacking influenza on multiple fronts as they search for a universal vaccine that protects people from the flu virus that often mutates year to year with deadly consequences. [More]
New discovery could help efforts to produce more effective vaccines

New discovery could help efforts to produce more effective vaccines

The best defense is a good offense, especially when it comes to the immune system. The troops that respond to an infection are split into two squadrons, and, until recently, it seemed that the two were independent, without much interaction. [More]
FDA approves use of Menactra for booster vaccination against meningococcal disease

FDA approves use of Menactra for booster vaccination against meningococcal disease

Sanofi Pasteur, the vaccines division of Sanofi, announced today that the U.S. Food and Drug Administration approved use of Menactra® [Meningococcal (Groups A, C, Y and W-135) Polysaccharide Diphtheria Toxoid Conjugate Vaccine] for booster vaccination against meningococcal disease in persons 15 years through 55 years of age. [More]
New breast cancer vaccine provides evidence of immunotherapy in preventing disease recurrence

New breast cancer vaccine provides evidence of immunotherapy in preventing disease recurrence

A new breast cancer vaccine candidate, (GP2), provides further evidence of the potential of immunotherapy in preventing disease recurrence. This is especially the case for high-risk patients when it is combined with a powerful immunotherapy drug. [More]
Viewpoints: End-of-life discussions; seniors missing their vaccinations; health law's new political calculations

Viewpoints: End-of-life discussions; seniors missing their vaccinations; health law's new political calculations

There is reason to hope that a degree of sanity may be returning to the touchy issue of advance planning for medical care at the end of life. [More]